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Summary
Background and objectives Individuals with chronic kidney disease (CKD) stages 3 to 5 have an increased
risk of cardiac and other vascular disease. Here we examined the association of CKD 3 to 5 with small ves-
sel caliber.
Design, setting, participants, & measurements This was a cross-sectional observational study of 126 patients
with CKD stages 3 to 5 (estimated GFR [eGFR] 60 ml/min per 1.73 m2) and 126 age- and gender-matched
hospital patients with CKD 1 or 2. Retinal vessel diameters were measured from digital fundus images by a
trained grader using a computer-assisted method and summarized as the central retinal artery equivalent
(CRAE) and central retinal vein equivalent (CRVE).
Results Patients with CKD 3 to 5 had a smaller mean CRAE and CRVE than hospital controls (139.4  17.8
m versus 148.5  16.0 m, P  0.001; and 205.0  30.7 m versus 217.4  25.8 m, respectively; P 
0.001). CRAE and CRVE decreased progressively with each stage of renal failure CKD1–2 to 5 (P for
trend  0.08 and 0.04, respectively). CKD and hypertension were independent determinants of arteriolar
narrowing after adjusting for age, gender, diabetes, dyslipidemia, and smoking history. Patients with CKD
5 and diabetes had a larger mean CRAE and CRVE than nondiabetics (141.4  14.9 m versus 132.9  14.2
m; 211.1  34.4 m versus 194.8  23.8 m).
Conclusions The microvasculature is narrowed in patients with reduced eGFR.
Clin J Am Soc Nephrol 6: 1872–1878, 2011. doi: 10.2215/CJN.10291110
Introduction
Individuals with renal impairment (chronic kidney
disease [CKD] stages 3 to 5) have an increased risk of
macrovascular disease, with cardiac mortality 20
times greater than in the nonrenal population (1) and
an increased likelihood of cerebrovascular, aortic, and
peripheral vascular disease (2–4). Even patients with
CKD stages 3 and 4 have an increased risk of vascular
disease (5), which in these early stages is associated
with the traditional risk factors of age, gender, hyper-
tension, diabetes, smoking, dyslipidemia, and family
history. The mechanisms are less well understood in
late disease but include “nontraditional” risk factors
such as systemic inflammation, oxidative stress, vas-
cular calcification, endothelial dysfunction, prothrom-
botic tendency, and anemia (6).
Microvascular disease is also common in CKD but
has been described as the “Cinderella of uremic heart
disease,” important but neglected (7). Cardiac micro-
vascular disease results from increased extravascular
resistance from left ventricular failure and interstitial
fibrosis and from an abnormal arteriole and capillary
structure (7). Patients with CKD have an increased
risk of lacunar infarcts, and up to 70% of dialysis
patients aged over 55 have some degree of cognitive
impairment that is probably microvascular in origin
(8–10). Even progressive renal failure may be due in
part to small vessel disease (11,12).
The microvasculature can be visualized directly in
the retina. Focal abnormalities include localized vessel
narrowing, arteriovenous nicking, hemorrhage, microa-
neurysms, and soft exudates (13,14). Generalized retinal
arteriolar narrowing typically reflects permanent or per-
sistent damage usually from atherosclerosis or long-
standing hypertension (15). Recent advances in the quan-
tification of retinal vascular caliber provide an accurate
and reproducible measure of arteriolar narrowing
(16–18), and caliber changes closely parallel micro-
vascular disease elsewhere in the body (19). Popula-
tion-based studies suggest that retinal microvascular
disease predicts cardiovascular events in other high-
risk populations including those with diabetes or dys-
lipidemia (20–23). This study determined the associ-
ation between CKD 3 to 5 and retinal vascular caliber,
and the role of the major determinants of caliber.
Materials and Methods
Study Population
The patients in this study were part of a cohort whose
retinal changes have been described in reference (39).
This was a cross-sectional observational study of 151
hospital patients with CKD 3 to 5 (estimated GFR
[eGFR]60 ml/min per 1.73 m2 for at least 3 months)
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from any cause (24). Their eGFR was calculated from the
serum creatinine concentration in mmol/L using the Mod-
ification of Diet in Renal Disease equation (25). Proteinuria
was not taken into account. Consecutive patients were
invited to participate during a weekly renal clinic at each of
two metropolitan teaching hospitals over a period of 18
months, and from the general medical ward at one of these
sites on certain days over a 3-month period. Patients who
had a renal transplant were excluded because of a possible
effect on retinal caliber. The participation rate in the pri-
mary study was greater than 80%. However, the retinal
photographs in only 126 patients (83.4%) were suitable for
microvascular grading and are described here.
Controls were patients with CKD 1 to 2 (eGFR 60
ml/min per 1.73 m2) recruited from the wards and clinic at
the same time as patients with CKD 3 to 5, but age- and
gender-matched. Further medical details and the presence
of any retinal disease were not known at the time of
recruitment for any of the patients. This study was ap-
proved by the Human Research Ethics Committee of
Northern Health and Austin Health in accordance with the
Principles of Helsinki, and all participants provided
signed, informed consent.
Study Assessments
Participants completed a structured questionnaire that
included their medical details, traditional macrovascular
risk factors, and current medications. Hospital records
were used to confirm details and obtain laboratory test
results. Hypertension was diagnosed with a systolic BP of
140 mmHg or diastolic pressure of 90 mmHg; diabetes
with a random glucose measurement of 11.0 mmol/L;
and dyslipidemia with serum cholesterol 5.0 mmol/L or
HDL 2.0 mmol/L. These diseases were also diagnosed if
self-reported as physician diagnosed or treated.
Retinal Imaging and Caliber Measurements
Patients underwent color retinal photography of both
eyes after dark adaptation or dilation with 1% tropicamide
using a KOWA 7 (Optimed) or Canon CR5–45NM (Canon)
nonmydriatic digital retinal camera. Standard 45o images
were taken of both eyes, with at least one view centered on
the macula and another on the optic disc.
A trained grader at the Centre for Eye Research Austra-
lia (Melbourne, Australia), who was masked to subject
identity, CKD stage, and other clinical details, evaluated
the digital retinal images using a standardized protocol.
Retinal vessel width was measured from the images using
a method described previously (16,26). Briefly, all vessels
coursing through a zone 0.5 to 1.0 disc diameters from the
disc margin were measured using a computer imaging
program (University of Wisconsin). Summary measures on
the basis of the six largest vessels referred to as the central
retinal artery equivalent (CRAE) and the central retinal
vein equivalent (CRVE) were calculated using the formu-
lae proposed by Knudtson et al. (27). The reproducibility of
retinal vascular measurements was very high, with intra-
class correlation coefficients of 0.99 (95% confidence inter-
val [CI] 0.98 to 0.99) for the CRAE and 0.94 (95% CI 0.92 to
0.96) for the CRVE.
Statistical Analyses
The categorical data were recorded in contingency tables
and reported as frequencies and percentages. Mean and SD
or median and range were used for continuous data. Fish-
er’s two-tailed test and the unpaired t test were used to
compare the baseline characteristics of patients with CKD
3 to 5 and controls with CKD 1 to 2. Differences between
the mean CRAE and CRVE values for patients and controls
were compared using the unpaired t test.
CRAE and CRVE were then categorized into quartiles,
and the difference in values for the first and fourth quar-
tiles calculated. Finally, the determinants of CRAE and
CRVE were examined in a linear regression model after
adjusting for various risk factors. All statistical analyses
were performed using STATA version 10 software (Stata-
Corp, College Station, TX).
Results
Clinical Features and Vascular Risk Factors in Patients
with CKD 3 to 5 (Table 1)
The 126 patients with CKD stages 3 to 5 included 82 men
(65%) and 44 women (35%), with a median age of 61 years
(range, 20 to 84) (Table 1). They had CKD stage 3 (n  44,
35%), CKD 4 (n  31, 25%), or CKD5 (n  51, 40%), and
their mean eGFR was 24.3 ml/min per 1.73 m2 (range
Table 1. Characteristics of patients with CKD 3 to 5 or CKD 1 to 2
Characteristic
Patients with CKD
3 to 5
(n  126)
Hospital Controls with
CKD 1 to 2
(n  126)
Odds
Ratio
95% Confidence
Interval P
Age (median, range) 61 (20 to 84) 60.5 (20 to 84) 0.97
Gender (male, %) 82 (65.1%) 82 (65.1%) 1.00 0.60 to 1.68 1.00
eGFR, (mean, SD, ml/min
per 1.73 m2)
24.3 (16.4) 84.1 (8.1) 0.01
Hypertension (%) 101 (80.2%) 56 (44.4%) 5.05 2.88 to 8.85 0.01
Number of antihypertensives
(mean, SD)
2.3 (1.4) 0.94 (1.2) 0.01
Diabetes (%) 46 (36.5%) 29 (23.0%) 1.92 1.11 to 3.34 0.03
Dyslipidemia (%) 86/124 (69.4%) 52/122 (46.2%) 3.05 1.80 to 5.14 0.01
Smoking history (%) 67 (53.2%) 84 (66.7%) 0.57 0.34 to 0.95 0.04
eGFR, estimated GFR; CKD, chronic kidney disease.
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459). Renal disease was due to diabetes (37, 29%), glo-
merulonephritis (35, 28%), hypertension/renovascular dis-
ease (22, 17%), reflux nephropathy and other structural
malformations (6, 5%), polycystic kidney disease (5, 4%), or
miscellaneous causes (cancer, trauma, nephrotoxic agents,
or unknown; 21, 17%).
Patients with CKD 3 to 5 were more likely to have
hypertension (P  0.001), require more antihypertensives
(P  0.001) and have diabetes (P  0.03) or dyslipidemia
more often (P  0.001) than age- and gender-matched
patients with CKD 1 to 2. However, patients with renal
failure were less likely to have smoked (P  0.04). HbA1C
levels were not different between diabetics with CKD 3 to
5 and CKD 1 to 2 (7.6  2.2 and 8.16  2.31, respectively,
mean difference 0.56, 95% CI 1.46 to 0.38, P  0.25).
Retinal Vessel Caliber Decreases with Lower eGFR
Patients with CKD 3 to 5 had a smaller CRAE and CRVE
than those with CKD 1 to 2 (P  0.001 and P  0.001)
(Table 2). There was a significant trend for CRAE to de-
crease between the groups with CKD 3 and CKD 5 (P for
trend  0.08), and CRVE was less in CKD 5 than in CKD 3
(P  0.04) (Table 2).
Retinal Vessel Caliber Is Increased in CKD 5 in Diabetics
Compared with Nondiabetics
CRAE and CRVEwere larger in patients with CKD 5 and
diabetes (n 17, 141.4 14.9 m; 211.1 34.4 m) than in
nondiabetics (n  34, 132.9  14.2 m, P  0.05; 194.8 
23.8 m, P  0.05).
Retinal Arteriolar Caliber in CKD 3 to 5 Depends on
eGFR and Hypertension
When patients with CKD 3 to 5 or with CKD 1 to 2 were
studied together, those with a CRAE in the first or lowest
quartile had a lower eGFR (43.9 compared with 66.6 ml/
min per 1.73 m2, P  0.01) and were 3.5 times more likely
to have CKD 3 to 5 than those with a CRAE in the fourth
or highest quartile (63.5% compared with 33.3%, odds ratio
[OR] 3.48, 95% CI 1.67 to 7.24; P  0.001) (Table 3). This
was significant after adjusting for age, gender, hyperten-
sion, diabetes, dyslipidemia, and smoking history (ad-
justed OR 2.84, 95% CI 1.25 to 6.46; P  0.013) (Table 4).
CRAE did not depend on HbA1C in diabetic patients with
CKD 3 to 5 after adjusting for age, gender, hypertension,
and eGFR (OR 0.79, 95% CI 0.79 to 2.37, P  0.32).
Patients with CRAE in the first quartile were also more
likely to have hypertension (P 0.001) and to require more
antihypertensive medications (P  0.001; Table 3). This
was significant after adjusting for the other variables (ad-
justed OR 3.94, 95% CI 1.52 to 10.2, P  0.001).
Retinal Venular Caliber in CKD 3 to 5 Depends on eGFR
When patients with CKD 3 to 5 or with CKD 1 to 2 were
studied together, those with a CRVE in the first quartile
had a lower eGFR (37.3 compared with 60.8 ml/min per
1.73 m2, P  0.0001) and were four times more likely to
have CKD 3 to 5 than those with a CRVE in the fourth
quartile (76.2% compared with 44.4%, OR 4.00, 95% CI 1.86
to 8.58; P  0.001) (Table 5). This association was signifi-
cant after adjusting for age, gender, hypertension, diabetes,
dyslipidemia, and smoking history (adjusted OR 4.75, 95%
CI 2.00 to 11.3, P  0.001) (Table 6). CRVE did not depend
on HbA1C in diabetic patients with CKD 3 to 5 after
adjusting for age, gender, hypertension, and eGFR (OR
1.29, 95% CI 1.76 to 4.33, P  0.40).
Discussion
This study demonstrated that retinal arterioles and
venules are narrowed in renal failure and that the narrow-
ing worsens as kidney function declines. Renal failure and
hypertension are independent determinants of microvas-
cular narrowing even after adjusting for the traditional
vascular risk factors of age, gender, diabetes, dyslipidemia,
and smoking. Furthermore, the relative vasodilatation de-
scribed in diabetics with normal renal function persists in
CKD 5 when the narrowing associated with kidney failure
is otherwise maximal.
Retinal microvascular changes have been studied previ-
ously in different populations with renal failure. In two
epidemiologic series, focal arteriolar narrowing, arterio-
venous nicking, and hemorrhage were increased (28,29).
However, interpretation of these signs is subjective, and
our study instead used computer-assisted measures of ves-
sel caliber that were quantitative, standardized, and highly
reproducible.
Retinal vascular caliber has also been examined previ-
ously in patients with renal disease using large population-
based cohorts and in type 1 diabetics. However, the results
have been contradictory. In one of the epidemiologic stud-
ies, retinal arterioles were narrowed in individuals with
Table 2. Retinal vascular caliber and stage of CKD
Characteristic CKD 1 to 2(n  126)
CKD 3 to 5
(n  126) P
a CKD 3
(n  44)
CKD 4
(n  31)
CKD 5
(n  51) P trend
b
Age (years, median,
range, years)
60.5 (20 to 84) 61 (20 to 84) 0.97 63 (29 to 82) 61 (38 to 83) 60 (20 to 84) 0.33
Gender (male, %) 82 (65.1%) 82 (65.1%) 1.00 24 (54.5%) 25 (80.6%) 33 (64.7%) 0.40
CRAE (mean, SD, m) 148.5 (16.0) 139.4 (17.8) 0.001 141.9 (18.7) 142.0 (20.4) 135.7 (14.8) 0.08
CRVE (mean, SD, m) 217.4 (25.8) 205.0 (30.7) 0.001 213.4 (34.4) 201.1 (27.0) 200.2 (28.5) 0.04
AVR (mean, SD, m) 0.69 (0.08) 0.69 (0.08) 0.893 0.67 (0.07) 0.71 (0.10) 0.68 (0.08) 0.58
CKD, chronic kidney disease; CRAE, central retinal artery equivalent; CRVE, central retinal vein equivalent.
aBetween CKD 1 to 2 and CKD 3 to 5.
bBetween CKD 3 and CKD 5.
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impaired renal function or albuminuria (30), but renal
impairment was mild, and the median eGFR for each
CRAE quartile was within the normal range. In patients
with type 1 diabetes, the presence of proteinuria was as-
sociated with smaller vessels (23), and renal impairment
with larger caliber vessels (31). Our study was the first to
examine retinal vessel caliber in hospital-based patients
with renal failure, and the effect of renal failure on vessel
size was obvious. This was true even though nearly 40% of
our patients had diabetes that typically produces relative
dilation.
Our study found that retinal arterioles were narrowed in
renal impairment. Arteriolar narrowing is usually due to
hypertension, atherosclerosis, and, rarely, retinal edema or
ischemia after, for example, panretinal photocoagulation
(32). Retinal arteriolar narrowing in CKD depended on
hypertension and CKD but not the other traditional vas-
cular risk factors. Vascular narrowing worsened as renal
function deteriorated, suggesting that microvascular dis-
ease in the kidney itself might contribute to progressive
kidney failure or that there was a common pathogenesis.
Retinal veins were also narrowed in renal impairment
and became narrower as renal function declined. Retinal
venular caliber typically parallels arteriolar caliber. CRVE
has been studied previously in renal failure, but in all cases
venules were dilated (23,30,33). Venular dilation also oc-
curs in hypertriglyceridemia (33), diabetes (34), obesity
(35), smoking (36), and systemic inflammation (37). Venu-
lar dilation in renal failure in the previously-reported se-
ries may have reflected the prevalence of diabetes and the
use of albuminuria rather than eGFR to identify renal
impairment.
Our study suggested that although arterioles and
venules became smaller with progressive renal impair-
ment, the vessels in end-stage renal failure were still rela-
tively dilated in diabetics. Vasodilation of small vessels in
diabetes is thought to be inflammatory in nature, and
vasodilatation in end-stage renal disease is consistent with
the ongoing consequences of diabetes in addition to the
effects of hypertension and atherosclerosis.
The major strength of this study was that it examined a
large population of well characterized but typical hospital
patients with CKD 3 to 5 and demonstrated a narrowed
microvasculature compared with hospital patients with
CKD 1 to 2. Patient selection itself was unbiased because
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Table 4. Determinants of CRAE in patients with CKD
Characteristic Odds Ratio
95%
Confidence
Interval
P
Age 1.02 0.98 1.06 0.41
Male gender 0.73 0.28 1.89 0.51
CKD 3–5 2.84 1.25 6.46 0.01
Hypertension 3.94 1.52 10.2 0.01
Diabetes 0.60 0.24 1.47 0.26
Dyslipidemia 1.10 0.49 2.47 0.83
Smoking history 1.13 0.47 2.73 0.79
Log-likelihood  74.17. Probability  2  0.002. CRAE,
central retinal artery equivalent.
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consecutive patients were approached to participate in the
study by a team member who was not aware of their
medical histories or retinal appearance. There is no reason
to believe that the 25 patients recruited to the larger study
whose retinal photographs were ungradable had any fea-
tures that might have biased the results. In almost all cases,
their optic fundi could not be visualized because of cata-
racts.
Although the population with CKD 3 to 5 was not ho-
mogeneous, but rather comprised individuals with well- or
poorly-controlled BP, and both diabetics and nondiabetics,
the study still demonstrated that the microvasculature was
narrowed compared with patients with CKD 1 to 2. The
choice of antihypertensive medication was at the discretion
of the individual clinicians, but regardless has little effect
on microvascular caliber (38). Furthermore, we were able
to adjust for these variables in the multivariate analysis.
Another strength was that this study measured retinal
vessel caliber using a quantitative, precise, and highly re-
producible method.
A major limitation of this study was that it was unable to
demonstrate a causal relationship between CKD 3 to 5 and
microvascular narrowing. This requires a longitudinal
study. A further limitation is that it has not addressed
whether retinal microvascular narrowing predicts cardiac
events in CKD, but we will examine cardiac events in this
cohort over the next 2 years. Despite these limitations, this
study still demonstrates clearly that systemic microvascu-
lar disease is more common in patients with CKD 3 to 5
than in other hospital patients.
Are these results generalizable to other cohorts of pa-
tients with CKD 3 to 5? Our patients were mainly male,
aged 61 years, with a mean eGFR of 24 ml/min per 1.73 m2.
80% had hypertension, 36.5% had diabetes, 69% had dys-
lipidemia, and 53% were former smokers. Clinicians must
determine how closely these features are characteristic of
their own CKD populations.
Conclusions
Microvascular disease is a neglected aspect of the in-
creased cardiac risk in patients with renal failure. This
study demonstrated that microvascular disease is in-
creased in hospital patients with CKD 3 to 5 compared
with other patients. In addition, it suggests that any studies
of retinal vessel caliber must control for renal impairment.
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Table 6. Determinants of CRVE in patients with CKD
Characteristic Oddsratio
95% Confidence
Interval P
Age 1.02 0.99 to 1.06 0.17
Male gender 0.60 0.24 to 1.48 0.27
CKD 3–5 4.75 2.00 to 11.3 0.01
Hypertension 1.63 0.64 to 4.15 0.30
Diabetes 0.50 0.21 to 1.22 0.13
Dyslipidemia 0.84 0.37 to 1.93 0.69
Smoking history 1.00 0.44 to 2.26 0.99
Log-likelihood  72.91. Probability  2  0.003. CRVE,
central retinal vein equivalent; CKD, chronic kidney disease.
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